Krystal Biotech, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Pittsburgh, PA
KRYS chart
What traders are saying about $KRYS
Latest postsKrystal Biotech, Inc. news
- Krystal Biotech to Present at Upcoming Investor Conferences
Yahoo Finance ·
- Krystal Biotech Inc (4KB.HA) stock price, news, quote and history
Yahoo Finance Singapore ·
- Weekly Recap: KB113 lesion regression and reduced costs, $400M buyback
TradingView ·
- Krystal Biotech, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:KRYS) 2026-11-07
Seeking Alpha ·
- What Early Krystal Biotech Buyers Saw
Simply Wall St ·
- Krystal Biotech Inc (4KB.DE) balance sheet
Yahoo Finance UK ·
- Krystal Biotech Inc (4KB.DE) interactive stock chart – Yahoo Finance
Yahoo Finance Singapore ·
- Krystal Biotech Inc (4KB.DE) stock price, news, quote and history
Yahoo Finance UK ·
- Citi Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $412
Moomoo ·
- Krystal Biotech, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next
Moomoo ·
- Conferencia de resultados del T3 de 2026 de Krystal Biotech (KRYS): Los ingresos de VYJUVEK aumentan un 30%
TradingKey ·
- How Investors Are Reacting To Krystal Biotech (KRYS) Earnings Beat And Buyback
Simply Wall St ·
Krystal Biotech, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $389.1M | $290.5M | $50.7M | $0 |
| Net income | $204.8M | $89.2M | $10.9M | -$140.0M |
| Diluted EPS | $6.84 | $3.00 | $0.39 | $-5.49 |
| Total assets (year end) | $1.33B | $1.06B | $818.4M | $558.5M |
| Cash and equivalents (year end) | $496.3M | $344.9M | $358.3M | $161.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Krystal Biotech, Inc.
- Ticker
- KRYS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Pittsburgh, PA
- Fiscal year end
- December 31
- SEC CIK
- 1711279
Frequently asked questions
What exchange is Krystal Biotech, Inc. listed on?
Krystal Biotech, Inc. trades on the Nasdaq under the ticker symbol KRYS.
What industry is Krystal Biotech, Inc. in?
Krystal Biotech, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Krystal Biotech, Inc. headquartered?
Krystal Biotech, Inc.'s business address on file with the SEC is in Pittsburgh, PA.
When does Krystal Biotech, Inc.'s fiscal year end?
Krystal Biotech, Inc.'s fiscal year ends on December 31.
How much revenue did Krystal Biotech, Inc. report?
Krystal Biotech, Inc. reported $389.1M in revenue for calendar year 2025, according to its SEC filings.